Literature DB >> 24375229

Influence of hydrophilic amino acids and GC-content on expression of recombinant proteins used in vaccines against foot-and-mouth disease virus in Escherichia coli.

Hongfei Wei1, Mingli Fang, Min Wan, Hua Wang, Peiyin Zhang, Xiaoping Hu, Xiuli Wu, Ming Yang, Yongsheng Zhang, Lei Zhou, Chengfeng Jiao, Li Hua, Wenzhen Diao, Yue Xiao, Yongli Yu, Liying Wang.   

Abstract

Epitope-based protein expression in Escherichia coli can be improved by adjusting its amino acid composition and encoding genes. To that end, we analyzed 24 recombinant epitope proteins (rEPs) that carry multiple epitopes derived from VP1 protein of foot-and-mouth disease virus. High level expression of the rEPs was attributed to a high content of Arg, Asn, Asp and Thr, a low content of Gln, Pro and Lys, a high content of hydrophilic amino acids and a higher isoelectric point value resulting from abundant Arg. It is also attributed to the appropriate guanine and cytosine content in the encoding genes. The data provide a reference for adjusting the amino acid composition in designing epitope-based proteins used in vaccines and for adjusting the synonymous codons to improve their expressions in E. coli.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24375229     DOI: 10.1007/s10529-013-1421-1

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  2 in total

1.  PERISCOPE-Opt: Machine learning-based prediction of optimal fermentation conditions and yields of recombinant periplasmic protein expressed in Escherichia coli.

Authors:  Kulandai Arockia Rajesh Packiam; Chien Wei Ooi; Fuyi Li; Shutao Mei; Beng Ti Tey; Huey Fang Ong; Jiangning Song; Ramakrishnan Nagasundara Ramanan
Journal:  Comput Struct Biotechnol J       Date:  2022-06-03       Impact factor: 6.155

2.  Salt-Dependent Aggregation and Assembly of E coli-Expressed Ferritin.

Authors:  Wei Sun; Chengfeng Jiao; Yue Xiao; Luowei Wang; Cheng Yu; Jialin Liu; Yongli Yu; Liying Wang
Journal:  Dose Response       Date:  2016-02-26       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.